Expert says: Reaction to the Zimmerman verdict proves that the issues Martin Luther King, Jr. raised fifty years ago remain central challenges in American life
Wake Forest University
The American Society of Clinical Oncology (ASCO) is now recommending that physicians discuss use of the aromatase inhibitor exemestane (Aromasin) to prevent breast cancer in at-risk postmenopausal women. Two breast cancer experts at the University of Maryland Greenebaum Cancer Center are available to comment on the new guideline.